2003
DOI: 10.1016/s1525-2167(03)90978-4
|View full text |Cite
|
Sign up to set email alerts
|

854 Transcranial Doppler or transoesophageal echocardiography for the detection of venous-to-arterial circulation shunts

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2006
2006
2009
2009

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(9 citation statements)
references
References 0 publications
0
9
0
Order By: Relevance
“…Our study was not sufficiently powered, as we based the original power calculations on a pilot study done before v-aCS criteria for patent foramen ovale (significant v-aCS) had been worked out 16. Percutaneous closure of patent foramen ovale is used increasingly for atrial septal aneurysms with multiple embolic events.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…Our study was not sufficiently powered, as we based the original power calculations on a pilot study done before v-aCS criteria for patent foramen ovale (significant v-aCS) had been worked out 16. Percutaneous closure of patent foramen ovale is used increasingly for atrial septal aneurysms with multiple embolic events.…”
Section: Discussionmentioning
confidence: 99%
“…For participants who had unilateral monitoring of middle cerebral arteries, we duplicated the number of embolic signals to equate to bilateral monitoring. We based the criteria for “significant” v-aCS on our study comparing transcranial Doppler with the diagnosis of patent foramen ovale on transoesophageal echocardiography 16. As we use a rigorously standardised protocol for provocation testing, we prefer the following definition of significant v-aCS to that of the International Consensus Committee 27.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…TCD monitoring of MCA with injection of 'air in saline' ultrasound contrast was used for detection of v-aCS (as per the standardised protocol which is in keeping with the international consensus) [16]. Based on the previous validation study, a 'significant' v-aCS, indicative of patent foramen ovale (PFO), was defined as detection in MCA of 15 or more embolic signals with in 12 cardiac cycles of the injection of ultrasound contrast [17,18]. Venous blood was collected for lipid profile and apolipoprotein E allele and magnetic resonance imaging (MRI) of the brain was conducted to measure cerebrovascular disease.…”
Section: Methodsmentioning
confidence: 99%